Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

LOY-003

Source date not recordedAnalyse record ↗

Investigational daily oral drug intended to reduce growth-hormone and IGF-1 signaling associated with shorter lifespan in large and giant dogs.

Modality
once-daily oral veterinary tablet
Availability (US)
Veterinary investigational program with FDA reasonable-expectation-of-effectiveness acceptance; not approved
Biomarkers
growth hormone and IGF-1 levels; healthspan and age-associated disease outcomes in large dogs
Hallmark targeted
deregulated nutrient sensing, growth signaling, pet longevity
Kind
veterinary investigational drug